Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

UCB

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of UCB's 2013 CNS (central nervous system) sales performance.

UCB

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

Initially received a negative opinion of the drug. The EMA’s main advisory committee has changed its position on UCB and Amgen’s application for their severe osteoporosis drug Evenity, recommending ... UCB executive vice president Dr Pascale Richetta

Finalists

No Compromise For Her’ Creative Educational Campaign. by UCB Pharma S.A.

Darwinian leadership in the life sciences industry

Darwinian leadership in the life sciences industry industry, to use the words of UCB’s Jean- Christophe Tellier.

Second TULIP trial resurrects AZ’s lupus drug anifrolumab

Second TULIP trial resurrects AZ’s lupus drug anifrolumab BICLA has also been used in drug development programmes, for example with UCB’s lupus candidate epratuzumab, although that drug failed to show a significant impact on disease activity using the ... Benlysta has been a rare success in lupus, with a

Tecentriq’s triple negative breast cancer use among key CHMP nods

Tecentriq’s triple negative breast cancer use among key CHMP nods UCB’s Vimpat (lacosamide) also gained a thumbs up in the epilepsy market, with a recommendation in partial-onset seizures with or without secondary generalisation. ... On Friday the CHMP’s most notable ruling was a negative opinion for UCB and

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Using human insights to push healthcare communications forward
This blog highlights the value of human perspectives, showing how insights can propel healthcare communications forward to ultimately improve lives...
RWE Blog 4: The place of real-world evidence in the market access strategy
The fourth and final blog in our latest series focuses on market access strategy. This follows our evaluation of the role of real-world data (RWD) and real-world evidence (RWE) in...
RWE Blog 3: Is real-world evidence the holy grail
We began our four-blog series by evaluating the role of real-world data (RWD) and real-world-evidence (RWE) in Real-world challenges and real-world data, and understanding the payer's perspective, in Payers use...

Infographics